Fritextsökning
Innehållstyper
-
Merck Life Science A/S
-
Valves with piezo technology
Efficient control and regulation of gases in medical technology
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...
-
Compact and leak-tight powerhouse
Media-separated solenoid valve VYKA from Festo is virtually leak-free
-
New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)
-
Ny nivå av vakuum – helt utan olja.
Atlas Copco DHS 3000 VSD+ - Oljefri skruvvakuumpump för stora flöden!
-
Are you ready for EMC 2024?
Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.
-
Bio-Works
-
Quotient Sciences Limited
-
Healthcare study: Alzheimer’s blood test shows high accuracy
A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.
-
Han använder omsusade antikroppen – för hjärndiagnostik
De stora framstegen inom alzheimerbehandling på sistone har ökat behovet av pricksäker diagnostik på området. Forskare i Uppsala jobbar med att ta fram förbättr...
-
Affibody AB
-
Introducing ZEISS arivis Pro 4.2
ZEISS arivis software enhances custom microscopy image analysis.
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
Novo Nordisk to invest billions in new quality control lab
Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.
-
Reliably gripping and turning small parts
The extremely compact rotary gripper module EHMD is the ideal choice in many life science applications where small objects need to be gripped and turned in conf...
-
Medical plastics insights at Röchling
An exclusive look behind the scenes.
-
GSK pays 2.2 billion dollars to settle Zantac lawsuits
British drugmaker Glaxo Smith Kline, GSK, has struck a 2.2 billion dollar settlement, thereby resolving a vast majority of the liability cases pending against t...
-
Aurevia
-
Medicon Valley Alliance
-
Don't miss out on this unique opportunity
ZEISS QUALITY INNOVATION SUMMIT October 22 - 24 in Berlin.
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
GSK acquires oncology research company
GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.
-
MSD discontinues development of cancer drugs after trial failures
MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.